Zusammenfassung
Im Gegensatz zur Pathophysiologie ist die klinische Symptomatik der Erkrankung durch Clostridium difficile seit mindestens 15 Jahren gut bekannt, das therapeutische Vorgehen steht seither im Wesentlichen fest [Übersichten u.a. 2, 4, 6, 18, 36]. Dennoch scheint die Erkrankung im Bewußtsein der Ärzte noch nicht sicher verankert zu sein. Neben einer etwas unübersichtlichen Nomenklatur mag das an einem trotz aller Fortbildungsbemühungen mangelhaften Bekanntheitsgrad liegen. Insofern lohnt sich eine kurze Wiederholung der wichtigsten Tatsachen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anand A, Bashey B, Mir T, Glatt AE (1994) Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 89: 519–523
Bartlett JG (1994) Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18, S 265–272
Cartmill TDI, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E (1994) Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 27: 1–15
Fekety R (1995) Antibiotic-associated diarrhea and colitis. Current Opinion Infect Dis 8: 391–397
Fekety R, Silva J, Kauffman C, Buggy B, Gunner H (1989) Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 86: 15–19
Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J,jr (1995) Clostridium difficile- associated diarrhea and colitis. Infect Control Hosp Epidemiol 16: 459–477
Gryboski JD, Pellerano R, Young N, Edberg S (1991) Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol 86: 685–689
Heerze LD, Keim MA, Talbot JA, Armstrong GD (1994) Oligosaccharide sequences atta-ched to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis. J Infect Dis 169: 1291–1296
Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC (1995) Clostridium difficile colitis: An increasing hospital-acquired illness. Am J Surg 169: 480–483
Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN (1992) Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Int Med 117: 297–302
Keighley MRB, Burdon DW, Arabi Y, Alexander-Williams J, Thompson H, Youngs D, Johnson M, Bentley S, George RH, Mogg GAG (1978) Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhea. B Med J 2: 1667–1669
Krammer M, Karbach U (1993) Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride absorption. Z Gastroenterol 31: 73–77
Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 130: 989–993
Loeschke K (1980) Antibiotika-assoziierte Diarrhoe und Enterokolitis. Klin Wschr 58: 337–345
Loeschke K, Hauck R, Halbritter R, Pfaller P, Ruckdeschel G (1983) Clostridium difficile und Antibiotika-assoziierte Kolitis bei Risikopatienten: Zweimonatige epidemiologische Studie auf einer Intensiveinheit. Klin Wschr 61: 1081–1087
Loeschke K, Kautz U, Lohrs U (1980) Effects of antibiotics on caecal electrolyte transport and morphology in rats. Contribution to the pathogenesis of antibiotic-associated diarrhoea. Klin Wschr 58: 383–385
Loeschke K, Ruckdeschel G (1989) Antibiotikaassoziierte Kolitis - aktualisiert. Internist 30: 345–351
Loeschke K, Ruckdeschel G (1992) Durchfälle unter Antibiotika. Dtsch Ärztebl 89: B-221–224
Loeschke K, Tredup J, Ruckdeschel G (1984) Klinik der Antibiotika-assoziierten Kolitis. Fortschr Antimikr Antineopl Chemother (FAC) 3-3: 409–418
McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL (1995) Prevention of ß-Lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90: 439–448
McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z, Harrington G, Rubin M, Greenwald D (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271: 1913–1918
Nath SK, Thornley JH, Kelly M, Kucera B, On SLW, Holmes B, Costas M (1994) A sustained outbreak of Clostridium difficile in a general hospital: Persistence of a toxigenic clone in four units. Infect Control Hosp Epidemiol 15: 382–389
Nelson DE, Auerbach SB, Baltch AL, Desjardin E, Beck-Sague C, Rheal C, Smith RP, Jarvis WR (1994) Epidemic Clostridium difficile-associated diarrhea: Role of second- and third- generation cephalosporins. Infect Control Hosp Epidemiol 15: 88–94
Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN (1994) Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Int Med 120: 272–277
Pothoulakis C, Kelly CP, Joshi MA, Gao N, O’Keane CJ, Castagliuolo I, Lamont T (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104: 1108–1115
Prendergast TM, Marini CP, D’Angelo AJ,Sher ME, Cohen JR (1994) Surgical patients with pseudomembranous colitis: Factors affecting prognosis. Surgery 116: 768–775
Rubin MS, Bodenstein LE, Kent KC (1995) Severe Clostridium difficile colitis. Dis Colon Rectum 38: 350–354
Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW (1994) Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 18: 181–187
Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 96: 981–988
Surawicz CM, McFarland LV, Elmer G, Chinn J (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 84: 1285–287
Tedesco FJ, Gordon D, Fortson WC (1985) Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 80: 867–868
The Swedish CD AD Study Group (1994) Treatment of Clostridium difficile associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study. Scand J Infect Dis 26: 309–316
Tredup J (1985) Clostridium difficile im Stuhl: Klinische Bedeutung bei 110 Patienten aus Krankenhäusern in München. Med. Dissertation LMU München
Triadafilopoulos G, Hallstone AE (1991) Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 101: 685–691
Tumbarello M, Tacconelli E, Leone F, Cauda R, Ortona L (1995) Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Eur J Gastroenterol Hepatol 7: 259–263
Wehrmann T, Lembcke B (1995) Antibiotika-assoziierte Durchfälle. Z Gastroenterol 33 (Suppl 2): 35–40
Wilcox MH, Howe R (1995) Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicr Chemother 36: 673–679
Yee J, Dixon CM, McLean APH, Meakins JL (1991) Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 126: 241–246
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Loeschke, K. (1996). Klinik und Therapie der Clostridium difficile-Erkrankung. In: Kist, M., Caspary, W.F., Lentze, M.J. (eds) Ökosystem Darm VII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80327-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-80327-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61817-1
Online ISBN: 978-3-642-80327-7
eBook Packages: Springer Book Archive